The American Society of Health-System Pharmacists this week published updated guidelines for managing drug shortages. Developed by a leading expert on drug shortages, the guidelines offer strategies to minimize the impact of drug shortages on patient care. In its latest annual report to Congress on drug shortages, the Food and Drug Administration identified 39 new drug and biological product shortages in 2017, up from 26 in 2016, and 41 ongoing shortages from prior years. The agency recently announced a task force to address the root causes of the shortages.

Related News Articles

Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…